Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Debt Ratio (2020 - 2025)

Zevra Therapeutics' Debt Ratio history spans 8 years, with the latest figure at 0.22 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 34.89% year-over-year to 0.22; the TTM value through Dec 2025 reached 0.22, down 34.89%, while the annual FY2025 figure was 0.22, 34.89% down from the prior year.
  • Debt Ratio reached 0.22 in Q4 2025 per ZVRA's latest filing, down from 0.23 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.4 in Q2 2024 to a low of 30.05 in Q2 2022.
  • Average Debt Ratio over 5 years is 2.28, with a median of 0.24 recorded in 2025.
  • Peak YoY movement for Debt Ratio: surged 107.0% in 2024, then tumbled 41.37% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2021, then crashed by 348025.2% to 30.05 in 2022, then surged by 100.83% to 0.25 in 2023, then skyrocketed by 34.61% to 0.33 in 2024, then tumbled by 34.89% to 0.22 in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Debt Ratio are 0.22 (Q4 2025), 0.23 (Q3 2025), and 0.24 (Q2 2025).